Abstract: The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Abstract: The invention relates to c-Kit inhibitors useful in the treatment of cancers, and other serine-threonine kinase mediated diseases, having the Formula: (I) where A, L, R1, R2, R3, and n are described herein.

Abstract: The invention relates to HPK1 inhibitors useful in the treatment of cancers, and other serine-threonine kinase mediated diseases, having the Formula: where A, R1, R2, R3, R4, R5, R6, R16, R17, X1, X2, X3, X4, m, and n are described herein.

Abstract: The invention relates to c-Kit inhibitors useful in the treatment of cancers, and other -threonine kinase mediated diseases, having the Formula: (I) wherein A, L, R1, R2, R3, and n are described herein.

Abstract: A terminal component is applied to a speaker, and includes two terminals, a sleeve seat, and two fixing heads. Each terminal includes a terminal head and a terminal body. The sleeve seat includes two terminal blocks. The two terminal blocks respectively accommodate the two terminal bodies, so that the two terminal heads are exposed outside the sleeve seat. The two fixing heads are respectively combined with the two terminal heads, to respectively fasten two wires to the two terminals.

Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.

Abstract: A display method, apparatus, and program product for a bendable electronic device. The method determines whether a display of a bendable electronic device is in a planar first form or in a curved second form. The method displays a first interface of a first application in response to determining that the display is in the planer first form. The method displays a second interface that is available in the first application, the second interface adaptive to the curve second form, in response to determining that the display is in the curved second form is disclosed. An apparatus and/or a program product may perform the method.

Abstract: Provided is an electronic system and a control method for the electronic system. The electronic system includes a maintenance apparatus configured to maintain a position of the electronic system relative to a user in a case that the electronic system is worn by the user; a first acquisition apparatus configured to detect triggering data; and a processing apparatus configured to determine whether the triggering data meets a first condition, and control the electronic system to perform a preset function based on a result of the determination. When using a wearable electronic device including the electronic system, a user can control the electronic system to perform a preset function only by triggering the first acquisition apparatus, thereby simplifying the control operation. And the control method can be used for driving the electronic system to perform a preset function, thereby providing convenience in use.

Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.

Abstract: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.

Abstract: A display processing method, a display processing apparatus and an electronic device are described. The display processing method includes obtaining information from a second application when an interface of a first application is displayed in a predetermined region of a display screen of a display device; displaying prompt information on the information, on the interface of the first application; receiving a first operation on the prompt information; dividing the predetermined region into a first region and a second region, in response to the first operation; and displaying at least a part of the interface of the first application in the first region, and displaying an interface of the second application in the second region, wherein the information is displayed in the interface of the second application.

Abstract: An electronic device is provided, which includes: a maintaining body having at least a maintained state, where the maintaining body is capable of functioning as at least one portion of a ring or at least one portion of an approximate ring meeting a first condition, and the electronic device is maintained on an object via the maintaining body; a display including at least a first display portion and a second display portion, where the first display portion and the second display portion cannot be observed simultaneously in a case that the maintaining body is in the maintained state; and a controller configured to determine a display region for a content to be displayed among the first display portion and the second display portion, and control the content to be displayed to be displayed in the determined display region. A control method is further provided.

Abstract: A method for processing information and an electronic device are provided, in order to improve the performance of response of an electronic device. The method includes: obtaining environmental information of a current environment; determining, based on the environmental information, a first operation instruction corresponding to the electronic device and an execution parameter corresponding to the first operation instruction, where the execution parameter is a parameter selected among at least two execution parameters corresponding to the first operation instruction; and controlling the electronic device to perform a first operation corresponding to the first operation instruction based on the execution parameter.

Abstract: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.

Abstract: An electronic device includes a first body and a second body which are detachably connected. The first body includes a frame and a fixing apparatus, and the second body includes a main functional unit. The fixing apparatus is connected to the frame and configured to fix the electronic device to an operation body. When the electronic device is fixed to the operation body via the fixing apparatus, the fixing apparatus and the frame form a ring-shaped space. A method for controlling power supply of the electronic device is also provided.

Abstract: The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: wherein the variables are as defined herein.

Abstract: This invention relates to compounds of the general formula (I): in which the variable groups are as identified herein, and to preparation and use of the compounds.

Abstract: The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula I: wherein the variables are as defined herein.

Abstract: An information processing method and an electronic device are provided. The method includes: acquiring a first parameter related to a first behavior of a user of an electronic device, in a case that a current position of the electronic device is a first position, where the first behavior is a behavior which does not cause the electronic device to move; determining whether the first parameter meets a preset condition to obtain a first determination result; and adjusting the current position from the first position to a second position, in a case that it is determined that the first parameter meets the preset condition.

Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.